• Users Online: 208
  • Print this page
  • Email this page

    Article Cited by others


The impact of immune checkpoint inhibitor-related adverse events and their immunosuppressive treatment on patients' outcomes

Abu-Sbeih Hamzah, Tang Tenglong, Ali Faisal Shaukat, Johnson Daniel Hartman, Qiao Wei, Diab Adi, Wang Yinghong

Year : 2018| Volume: 1| Issue : 1 | Page no: 7-18

   This article has been cited by
1 Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors
Tenglong Tang,Hamzah Abu-Sbeih,Wenyi Luo,Phillip Lum,Wei Qiao,Robert S. Bresalier,David M. Richards,Yinghong Wang
Scandinavian Journal of Gastroenterology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Something old, something new: liver injury associated with Total parenteral nutrition therapy and immune checkpoint inhibitors
Cherise Meyerson,Bita V. Naini
Human Pathology. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Hamzah Abu-Sbeih,Faisal S. Ali,Abdul Rafeh Naqash,Dwight H. Owen,Sandipkumar Patel,Gregory A. Otterson,Kari Kendra,Biagio Ricciuti,Rita Chiari,Andrea De Giglio,Joseph Sleiman,Pauline Funchain,Beatriz Wills,Jiajia Zhang,Jarushka Naidoo,Jessica Philpott,Jianjun Gao,Sumit K. Subudhi,Yinghong Wang
Journal of Clinical Oncology. 2019; 37(30): 2738
[Pubmed]  [Google Scholar] [DOI]
4 Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement
Catherine R. Sears,Tobias Peikert,Jennifer D. Possick,Jarushka Naidoo,Mizuki Nishino,Sandip P. Patel,Philippe Camus,Mina Gaga,Edward B. Garon,Michael K. Gould,Andrew H. Limper,Philippe R. Montgrain,William D. Travis,M. Patricia Rivera
American Journal of Respiratory and Critical Care Medicine. 2019; 200(6): e31
[Pubmed]  [Google Scholar] [DOI]
5 Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
Ronald Anderson,Annette J. Theron,Bernardo L. Rapoport
Frontiers in Immunology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
6 Immune-Mediated Colitis
Tara Menon,Anita Afzali
Current Treatment Options in Gastroenterology. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis
Hamzah Abu-Sbeih,Faisal S. Ali,Xuemei Wang,Niharika Mallepally,Ellie Chen,Mehmet Altan,Robert S. Bresalier,Aline Charabaty,Ramona Dadu,Amir Jazaeri,Bret Lashner,Yinghong Wang
Journal for ImmunoTherapy of Cancer. 2019; 7(1)
[Pubmed]  [Google Scholar] [DOI]
8 Cancer Immunotherapy Related Endocrine Adverse Effects
Hana Kim,Sun Wook Cho,Young Joo Park
International Journal of Thyroidology. 2019; 12(2): 97
[Pubmed]  [Google Scholar] [DOI]
9 Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy
Hamzah Abu-Sbeih,Tenglong Tang,Faisal S. Ali,Wenyi Luo,Sattva S. Neelapu,Jason R. Westin,Pablo C. Okhuysen,Wai Chin Foo,Jonathan L. Curry,David M. Richards,Phillip S. Ge,Yinghong Wang
American Journal of Clinical Oncology. 2019; 42(10): 789
[Pubmed]  [Google Scholar] [DOI]


Read this article